Intuitive Surgical, Inc. $ISRG Shares Bought by TFG Advisers LLC

TFG Advisers LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.6% in the second quarter, HoldingsChannel reports. The firm owned 997 shares of the medical equipment provider’s stock after purchasing an additional 62 shares during the quarter. TFG Advisers LLC’s holdings in Intuitive Surgical were worth $542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Chilton Capital Management LLC raised its position in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. acquired a new position in Intuitive Surgical in the 1st quarter worth about $26,000. LFA Lugano Financial Advisors SA bought a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. TD Capital Management LLC boosted its stake in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. BTIG Research reaffirmed a “buy” rating and issued a $571.00 price target on shares of Intuitive Surgical in a report on Wednesday. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Friday, September 26th. Evercore ISI lifted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Fourteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Trading Down 2.1%

Shares of ISRG opened at $438.04 on Thursday. The stock has a market capitalization of $157.03 billion, a P/E ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The firm’s fifty day simple moving average is $465.33 and its two-hundred day simple moving average is $500.54. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.78 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.